Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.
about
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@en
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@nl
type
label
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@en
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@nl
prefLabel
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@en
Effect of adding bezafibrate t ...... bo-controlled crossover trial.
@nl
P2093
P2860
P356
P1476
Effect of adding bezafibrate t ...... ebo-controlled crossover trial
@en
P2093
A David Marais
Charlotte Koopal
Jan Westerink
Yolanda van der Graaf
P2860
P304
P356
10.1194/JLR.M076901
P577
2017-09-19T00:00:00Z